Topical anesthetics


NeuroMed7®  and NeuroMed BLT Topical Anesthetics Combination Package


Your comprehensive topical pain management solutions




Topical anesthetics that are time saving, cost effective solutions for skin numbing





NeuroMed products have a light creamy texture that won’t leave a waxy, oily, gritty or flaky residue like other products. Proprietary skin penetrating formula designed to reduce the amount of time for numbing to take effect from up to an hour for other numbing creams down to as little as 15 minutes for a full powerful effect.







  • Proprietary formula designed to speed onset time to as little as 15 minutes

  • Single-use, sanitary packets can reduce risk of cross contamination when compared to multi-use containers

  • Creamy, soft texture, does not leave, waxy, oily, gritty or flaky residue when applied or after removal

  • Very easy to apply and remove

  • Competitively priced in order to reduce clinical procurement cost

  • NeuroMed BLT Combination Package provides clinical options and flexibility unique to this product package not seen with any other competitive products




Topical Anesthetics

Sambria Pharmaceuticals supplies clinicians with NeuroMed 7 (4% lidocaine) and its NeuroMed BLT Variety Combination Package which includes: NeuroMed FA (benzocaine 20%), NeuroMed 7 (lidocaine 4%) and NeuroMed LA (tetracaine 2%). These products are also conveniently supplied in single-use, sanitary, metered dosed packets to mitigate the possibility of cross contamination. The pH of these products consistently presents between 6.8 – 7.2. All products are manufactured in accordance with FDA policy and in an FDA approved and monitored facility. Ingredients included to improve the rate of penetration include, ethoxydiglycol, MSM and propylene glycol.



QA tested three times throughout the manufacturing process to ensure the highest degree of quality prior to entry into the supply chain





Safe and Effective, Rapid Onset Topical Anesthetics (15 – 20 minute peak effect)

Features and Benefits

  • Rapid onset of action
  • Proven safe and effective both in clinical use settings as well as approved studies
  • Easy to apply and remove
  • Competitive cost
  • Two-year shelf life from time of manufacture
  • Third party tested for microbes and active ingredient concentration
  • Supplied in both convenient, metered dosed, single-use, sanitary packets and multi-use tubes (tubes are for NeuroMed7 only)
  • Easy access (no prescription required, designated OTC Monograph therapeutic anesthetic)
  • FDA Compliant in accordance with the 21 CFR Tentative Final Monograph 348 OTC Topical Analgesics and Anesthetics for Human Use



 Topical Anesthetics are Commonly Used to Reduce Pain Derived from:

  • Injection
  • Cannulation
  • Blood draw
  • Minimally invasive dermal instrumentation
  • Superficial aesthetic procedures
  • Superficial laser procedures


Topical anesthetics for needle stick



OTC TOPICAL – FDA MONOGRAPH COMPLIANT CFR 21 – Monograph 348 OTC Topical Analgesics and Anesthetics for Human Use


Contact Sambria™ Pharmaceuticals, llc via telephone (888.246.6601) or email or see your local medical device distributor to order products or more information.

Important Safety Information:

Indication: Topical Anesthetics are indicated for use on intact skin in adults and children 2 years and older to provide topical local analgesia for superficial dermatological conditions and procedures. Contraindications: NeuroMed Topical Anesthetic Creams are contraindicated in patients with a known history of sensitivity to lidocaine, or local anesthetics of the amide or ester type and is also contraindicated in patients with sensitivity to any component of the product. Warnings/Precautions: Methemoglobinemia has been associated with use of local anesthetics. Topical anesthetics should be used with caution in patients with severe hepatic disease. When using NeuroMed Topical Anesthetics Creams in conjunction with one another or combined with other local anesthetic agents, the total dose of anesthetic should be considered due to the potential for additive systemic toxic effects. Contact with the eyes should be avoided.

Get the best alternative to other current topical therapeutics and systemic drugs